Amikacin/cladribine/rituximab: Various toxicities : case report.

A 31-year-old man developed a Mycobacterium kansasii infection while being treated for hairy cell leukemia and tinnitus with cladribine and rituximab. He also experienced a rash and febrile pancytopenia. Further investigations revealed a diagnosis of hairy cell leukemia and hemochromatosis. The man was treated with azithromycin, ethambutol, rifampin, and amikacin, but developed bilateral tinnitus and decreased high frequency sound as a side effect of amikacin. His treatment was adjusted, resulting in improved infection control. [Extracted from the article]